Valuation: Veradigm Inc.

Market Cap 87Cr 77Cr 72Cr 66Cr 123.67Cr 8.39TCr 124.21Cr 866.69Cr 339.59Cr 4.28TCr 325.49Cr 318.37Cr 14TCr P/E 2025 *
-
P/E 2026 * -
Enterprise Value 11Cr 9.58Cr 8.91Cr 8.11Cr 15Cr 1.04TCr 15Cr 107.29Cr 42Cr 529.41Cr 40Cr 39Cr 1.7TCr EV / Sales 2025 *
0.18x
EV / Sales 2026 * -
Free-Float
36.8%
Yield 2025 *
-
Yield 2026 * -

Last Transcript: Veradigm Inc.

1 day+2.00%
1 week+2.00%
Current month-0.78%
1 month+12.09%
3 months+0.99%
6 months+13.33%
Current year+6.25%
1 week 4
Extreme 4
5.1
1 month 4
Extreme 4
5.14
Current year 3.25
Extreme 3.25
5.18
1 year 3.25
Extreme 3.25
6
3 years 3
Extreme 3
13.84
5 years 3
Extreme 3
23.25
10 years 3
Extreme 3
23.25
Manager TitleAgeSince
Chief Executive Officer 54 02/09/2025
Director of Finance/CFO 49 11/05/2026
Chief Tech/Sci/R&D Officer - 03/11/2025
Director TitleAgeSince
Director/Board Member 64 24/05/2016
Director/Board Member 65 08/08/2020
Director/Board Member 62 17/02/2023
Date Insider Type Main position Quantity % Market Cap. Importance
01/06/26
Stonehill Capital Management LLC
OtherCompany 0 0% -
01/06/26 Free

Director

42,507 0.0390%
01/06/26
Stonehill Capital Management LLC
FreeCompany 42,507 0.0390%
Change 5-day change 1-year change 3-year change Capi.($)
+2.00%+2.00%+5.70%-63.26% 87Cr
+0.93%+0.49%+25.38%+32.63% 24TCr
+1.08%+2.69%+8.57%+0.50% 15TCr
+2.06%+8.17%-1.31%+42.35% 15TCr
+1.64%+0.31%-55.21%-20.58% 6.19TCr
+1.15%+0.07%+15.24%+16.87% 4.91TCr
+2.30%+3.38%-17.09%-19.05% 4.88TCr
+1.41%+1.65%+24.83%+50.53% 4.81TCr
+3.96%+8.34%+3.33%+38.46% 4.79TCr
+1.08%+2.01%+31.05%+61.37% 4.26TCr
Average +1.76%+2.54%+4.05%+13.98% 8.47TCr
Weighted average by Cap. +1.51%+2.74%+7.65%+23.40%

Financials

2025 *2026 *
Net sales 58Cr 52Cr 49Cr 44Cr 83Cr 5.66TCr 84Cr 584.64Cr 229.07Cr 2.88TCr 219.56Cr 214.76Cr 9.26TCr -
Net income - -
Net Debt -76Cr -68Cr -63Cr -57Cr -108.36Cr -7.35TCr -108.83Cr -759.41Cr -297.55Cr -3.75TCr -285.19Cr -278.96Cr -12TCr -
Projected Income Statement - Annual - Veradigm Inc.
Logo Veradigm Inc.
Veradigm Inc. is a healthcare technology and analytics company. The Company offers platforms, solutions and services that help healthcare provider practices of all sizes and specialties with cloud-based and hosted electronic health record (EHR) platforms, practice management, revenue cycle services, and patient engagement tools. It operates through three segments, which include Provider, Payer, and Life Science. Its Provider business consists of two EHRs, practice management and revenue cycle management, which are patient engagement and enterprise resource planning solutions. Its Payer business delivers solutions that support the end-to-end risk adjustment and quality needs of health plans, spanning analytics, clinical data exchange, provider engagement, and regulatory submissions. Its Life Science Business includes a data and research platform and a commercial media business, which partners with life science and other healthcare companies.
Employees
2,300
Date Price Change Volume
09/26/09 $5.090 +1.80% 97,203
08/26/08 $5.000 -.--% 2,183
07/26/07 $5.000 -.--% 26,511
06/26/06 $5.000 -.--% 1,606
05/26/05 $5.000 -.--% 10,142
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
A
Ratings Surperformance© - Veradigm Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
5.090USD
Average target price
6.500USD
Spread / Average Target
+27.70%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Veradigm Inc.
  1. Stock Market
  2. Stocks
  3. MDRX Stock